Kake Zhao

Substituted indanylacetic acids as PPAR-α-γ activators

David P. Dickson, I. Muegge, Lei Zhu, 2006 .

From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.

Sujata Sharma, J. Lisnock, P. Orth, 2019, Cell chemical biology.

Design of potent and selective GPR119 agonists for type II diabetes.

A. Howard, P. Meinke, G. Chicchi, 2011, Bioorganic & medicinal chemistry letters.

Inhibition of dipeptidyl peptidase IV (DPP IV) by 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitrile, a fluoroolefin containing peptidomimetic.

Dongsung Lim, J. Welch, T. Funaki, 2003, Bioorganic & medicinal chemistry.

Invention of MK-8262, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor Backup to Anacetrapib with Best-in-Class Properties.

Joseph James Duffy, D. Johns, Rupesh P. Amin, 2021, Journal of medicinal chemistry.

Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach.

D. Johns, A. Crespo, P. Váchal, 2016, ACS medicinal chemistry letters.

From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9.

Sujata Sharma, P. Orth, J. Shipman, 2021, Cell chemical biology.